This study demonstrates that gut microbiota dysbiosis during HF progression exacerbates cardiac dysfunction by activating the TLR4/NF-κB signalling pathway via endogenous LPS, thereby driving myocardial inflammation and fibrosis. The gene discussed is NFKB1; the disease is hydrops fetalis.